Chinese Herbal Therapy Combined With Acupuncture for Female Mixed Urinary Incontinence
Combination Therapy With Chinese Herbal Formula, Yiqi Suoquan Granule, and Acupuncture for Female Mixed Urinary Incontinence
Sponsor study identifier
interventional
136
1 country
1
Study Start
March 14, 2018
Actual (reported)Primary Completion
April 18, 2021
Actual (reported)Study Completion
April 18, 2021
Actual (reported)The purpose of this study is to determine whether combination therapy with Chinese herbal formula, Yiqi Suoquan granule, and acupuncture is effective in the treatment of female mixed urinary incontinence.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 18, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 23, 2018
Actual (reported)March 1, 2018
Actual (reported)March 14, 2018
Actual (reported)April 18, 2021
Actual (reported)April 18, 2021
Actual (reported)Change in incontinence episode per 24 h
assessed by 72 h bladder diary
8 week (post-treatment) and 12 week (follow-up)
Change in ICIQ-SF questionnaire
8 week (post-treatment) and 12 week (follow-up)
Change in I-QOL questionnaire
8 week (post-treatment) and 12 week (follow-up)
proportion of participants with more than 50% improvement in incontinence episodes per 24h
8 week (post-treatment)
Participants will take Yiqi Suoquan granule and receive acupuncture.
Participants will take Yiqi Suoquan granule and receive sham acupuncture.
Participants will take Chinese herbal formula, Yiqi Suoquan granule, which is composed of Radix Astragali 30 g, Radix Codonopsis pilosula 10g, Radix Angelica sinensis 10g, Radix Atractylodis Macrocephalae 10g, Fructus Alpiniae Oxyphyllae 10g, Radix Lindera aggregata 6g, Rhizoma Dioscoreae 10g, pericarpium citri reticulatae 10g, Rhizoma Cimicifuga 10g, Radix Bupleuri 10g, Fructus Rubi 15g, and Semen raphani 10g and prepared by the Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences. Besides, Participants will receive acupuncture, three times a week. The selected acupoints include bilateral BL33, BL35, SP6, and ST36.
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, 100053, China
Ran Pang, MD
Guang'anmen hospital
136 participants (actual enrollment reported by the registry).
First Submitted
February 23, 2018
First Posted
March 1, 2018
Study Start
March 14, 2018
Actual (reported)Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
Participants will take placebo granule and receive acupuncture.
Participants will take placebo granule and receive sham acupuncture.
Participants will take Chinese herbal formula, Yiqi Suoquan granule, which is composed of Radix Astragali 30 g, Radix Codonopsis pilosula 10g, Radix Angelica sinensis 10g, Radix Atractylodis Macrocephalae 10g, Fructus Alpiniae Oxyphyllae 10g, Radix Lindera aggregata 6g, Rhizoma Dioscoreae 10g, pericarpium citri reticulatae 10g, Rhizoma Cimicifuga 10g, Radix Bupleuri 10g, Fructus Rubi 15g, and Semen raphani 10g and prepared by the Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences. Besides, Participants will receive sham acupuncture, three times a week. The sham BL33, BL35, SP6, and ST36, which are 25 mm outward to BL33, BL35, SP6, and ST36, will be inserted with a depth of 2 to 3 mm.
Participants will take Chinese herbal placebo which is prepared by the Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences. Besides, Participants will receive acupuncture, three times a week. The selected acupoints include bilateral BL33, BL35, SP6, and ST36.
Participants will take Chinese herbal placebo which is prepared by the Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences. Besides, Participants will receive sham acupuncture, three times a week. The sham BL33, BL35, SP6, and ST36, which are 25 mm outward to BL33, BL35, SP6, and ST36, will be inserted with a depth of 2 to 3 mm.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
April 18, 2021
Actual (reported)Study Completion
April 18, 2021
Actual (reported)Last Updated
June 1, 2021
Record last verified: 2021-05
The agreement for sharing IPD is not designed to be signed in informed consent form.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: